Endocrinology

Hyperprolactinemia

Also known as: Prolactinoma, Prolactin Excess

Elevated prolactin hormone levels, usually from a benign pituitary tumor, causing milky nipple discharge and infertility.

Source: Endocrine Society Clinical Practice Guideline

Updated: Aug 04, 2026

1,215 Views

Red Flag Warning & Emergency Situations

Sudden thunderclap headache indicating pituitary apoplexy.

Emergency Management: Pituitary apoplexy. Requires stat IV Hydrocortisone 100 mg and urgent neurosurgery.

Core Definition:

Hyperprolactinemia is the persistent elevation of serum prolactin. The most common pathological cause is a prolactinoma, a benign pituitary adenoma secreting prolactin, leading to hypogonadism and galactorrhea.

Detailed Overview

Prolactin is tonically inhibited by hypothalamic dopamine. Loss of this inhibition (via stalk compression or dopamine antagonist drugs) or autonomous tumor secretion raises prolactin. High prolactin suppresses GnRH, causing hypogonadotropic hypogonadism. First-line therapy is medical (dopamine agonists), uniquely highly effective at shrinking these tumors.

Epidemiology & Demographics

Prolactinomas account for 40% of pituitary tumors. More common in females aged 20-50 (microadenomas), while males often present later with macroadenomas.

Etiological Mechanism

Prolactinoma, pregnancy, primary hypothyroidism, and dopamine antagonist medications.

Primary Causes

Prolactinoma

Medications (antipsychotics, metoclopramide)

Antipsychotic use: Drugs like risperidone heavily block D2 receptors.
MEN1 Syndrome: Genetic predisposition to pituitary tumors.

Prolactinomas are monoclonal expansions of lactotrophs. Excess prolactin binds to receptors on the hypothalamus, suppressing pulsatile GnRH release. This decreases LH/FSH, shutting down gonadal steroidogenesis (estradiol/testosterone). Macroadenomas (>10mm) can compress the optic chiasm.

Characteristic Clinical Presentation

Amenorrhea/Oligomenorrhea: Absence of menses in females.
Galactorrhea: Milky nipple discharge.
Decreased libido and Erectile Dysfunction: Due to low testosterone in males.
Bitemporal hemianopsia: Loss of peripheral vision from optic chiasm compression.

Physical Examination Signs

Expressible galactorrhea.
Visual field deficits.
Testicular atrophy.

Clinical Risk: Uncontrolled or untreated conditions may progress to the following complications:

Osteoporosis: Due to prolonged hypogonadism.
Pituitary Apoplexy: Hemorrhage into tumor causing severe headache and vision loss.

Diagnostic Criteria & Guidelines

Persistently elevated prolactin without physiologic cause, combined with MRI evidence of a pituitary adenoma.

Differential Diagnosis

Pregnancy
Primary Hypothyroidism
Non-functioning pituitary adenoma (stalk effect)

Laboratory Tests & Biomarkers

Serum Prolactin: >200 ng/mL strongly suggests prolactinoma.
TSH: Normal (rules out primary hypothyroidism).
Beta-hCG: Negative.

Imaging Modalities & Findings

MRI Pituitary with contrast:

Microprolactinoma
<10 mm, mostly endocrine symptoms.
Macroprolactinoma
≥10 mm, risk of mass effect.

First-Line Treatment:

Cabergoline (D2 agonist) 0.25 mg PO twice weekly, titrated to normalize prolactin and shrink tumor.

Second-Line & Adjunctive Therapy

Bromocriptine 1.25 mg PO daily. Endoscopic transsphenoidal surgery if resistant/intolerant to meds.

Surgical & Procedural Management

Endoscopic endonasal transsphenoidal adenomectomy.

Recommended Lifestyle Changes

Calcium and Vitamin D supplementation for bone health.

Patient Counseling & Advice

Warn about nausea and orthostatic hypotension with cabergoline. Rare risk of impulse control disorders. Fertility often returns quickly, so use contraception if pregnancy is not desired.

Follow-Up & Monitoring Schedule

Prolactin levels every 1-2 months initially. Repeat MRI at 1 year. Visual field tests if macroadenoma.

Preventive Strategies

None.

Excellent. 80% achieve normal prolactin and tumor shrinkage on cabergoline.

Frequently Asked Questions

Yes, treatment restores normal fertility in most women.

Authoritative Sources & Evidence References

Endocrine Society Clinical Practice Guideline:
View Official Guideline

Key Literature & References:

Evidence Diagnosis and Treatment of Hyperprolactinemia